Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „weeks“
Suchtreffer
Begriffe & Kennungen
Casgevy · 4.5 · Discontinue the use of voxelotor and crizanlizumab at least 8 weeks prior to start of mobilisation and conditi
Eintrag öffnenCasgevy · 4.5 · Use of hydroxyurea/hydroxycarbamide must be discontinued at least 8 weeks prior to start of mobilisation and c
Eintrag öffnenCatiolanze · 4.8 · In two short term clinical trials (≤12 weeks), involving 93 (25 and 68) paediatric patients treated with prese
Eintrag öffnenCelsentri · 4.8 · Delayed type hypersensitivity reactions, typically occurring within 2-6 weeks after start of therapy and inclu
Eintrag öffnenCelsentri · 4.8 · Delayed type hypersensitivity reactions, typically occurring within 2-6 weeks after start of therapy and inclu
Eintrag öffnenCelsentri · 4.8 · The MOTIVATE studies were extended beyond 96 weeks, with an observational phase extended to 5 years in order t
Eintrag öffnenCelsentri · 4.8 · The MOTIVATE studies were extended beyond 96 weeks, with an observational phase extended to 5 years in order t
Eintrag öffnenCibinqo · 4.8 · Creatine phosphokinase elevations (CPK) In placebo-controlled studies, for up to 16 weeks, significant increas
Eintrag öffnenCibinqo · 4.8 · In placebo-controlled studies, for up to 16 weeks, the rate of serious infections was 1.81 per 100 patient-yea
Eintrag öffnenCibinqo · 4.8 · Infections In placebo-controlled studies, for up to 16 weeks, infections have been reported in 27.4% of patien
Eintrag öffnenCibinqo · 4.8 · Lipid elevations In placebo-controlled studies, for up to 16 weeks, there was a dose-related increase in low-d
Eintrag öffnenCibinqo · 4.8 · Lymphopenia In placebo-controlled studies, for up to 16 weeks, confirmed ALC < 0.5 × 103/mm3 occurred in 0.3%
Eintrag öffnenCibinqo · 4.8 · Nausea In placebo-controlled studies, for up to 16 weeks, nausea was reported in 1.8% of patients treated with
Eintrag öffnenCibinqo · 4.8 · Thrombocytopenia In placebo-controlled studies, for up to 16 weeks, treatment was associated with a dose-relat
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · Varicella vaccine It is recommended that patients not be given salicylates for an interval of six weeks after
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in a single arm, open-lab
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in a single arm, open-lab
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in an open- label clinica
Eintrag öffnen